Investors Eye Cannabis ETFs as Market Gains Momentum in 2026

The cannabis market is experiencing renewed interest as valuations decline and regulatory changes emerge. Following President Trump’s recent executive order reclassifying marijuana to a less dangerous category, some major players in the sector have seen significant gains. This shift might encourage investors to consider cannabis-focused exchange-traded funds (ETFs), particularly the AdvisorShares Pure US Cannabis ETF (MSOS), which has shown positive performance recently.

Understanding the AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF is an actively managed fund that tracks a diverse range of cannabis producers and hemp companies, with a specific focus on multi-state operators (MSOs). These MSOs are U.S.-based cannabis firms that operate in states where recreational marijuana sales are legal. While another ETF in this space, known as the MJ ETF, also tracks similar stocks, it leans more toward producers who have faced recent challenges. This difference in focus has contributed to the relative outperformance of MSOS.

Despite the positive momentum, the cannabis sector remains complex. U.S. cannabis companies are often limited to operating in specific locales due to varying state laws, creating a fragmented market landscape. As a result, many companies have adapted their strategies over time. Investors looking to capitalize on the potential long-term implications of federal legalization may find ETFs like MSOS to be promising vehicles for growth, contingent upon future developments.

Risks and Opportunities in the Cannabis Market

Investing in the cannabis sector carries inherent risks. Investors are not only wagering on the potential for federal legalization of marijuana but also on the profitability of companies within this industry. The imposition of various “sin” taxes on future cannabis sales could impact profitability. The experience of Canadian cannabis firms serves as a cautionary tale, as many have not achieved the success that was initially anticipated.

Despite these challenges, the MSOS ETF and others in the sector have performed well over the past year. A broader view reveals a more complex picture when analyzing performance over the past five years, a trend that reflects the overall volatility of the market. For investors with an appetite for risk and a long-term perspective, allocating a portion of their portfolio to MSOS could be beneficial.

While currently, I do not hold any positions in this sector, the recent developments offer potential catalysts that could influence future decisions. The MSOS ETF has gained momentum, marked by a significant spike in recent weeks, making it worth monitoring for those interested in cannabis investments.